Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Stephane Boissel
Individual Investor

Stephane Boissel

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Current Board & Advisor Roles 2
  • Investor Type 
    obfuscation
Stephane Boissel is based out of Paris, Ile-de-France, and is the President, CEO and Chairman of the Board of SparingVision and also the Chairman of the Board of Adocia. Stephane previously worked at EG 427 as a Board Member. Stephane Boissel attended the Université Paris-Dauphine.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Stephane Boissel invested in EG 427 on
obfuscation
. This investment - Series A - EG 427 - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
EG 427 Logo
EG 427
—
Series A - EG 427 Logo
Series A - EG 427
obfuscation

Jobs

Edit Jobs Section
Number of Current Jobs 3
Number of Past Jobs 1
Stephane Boissel has 3 current jobs including President at SparingVision, CEO at SparingVision, and Chairman & CEO at GAMUT Therapeutics. Additionally, Stephane Boissel has had 1 past job as the EVP Corporate Strategy at Sangamo Therapeutics.
Organization Name  
Title At Company  
Start Date  
End Date  
Sangamo Therapeutics Logo
Sangamo Therapeutics
EVP Corporate StrategyOct 2018Jul 2020

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 2
Number of Past Board & Advisor Roles 1
Stephane Boissel holds 2 board and advisor roles as Chairman of the Board at Adocia and Chairman of the Board at SparingVision.
Organization Name  
Title At Company  
Start Date  
End Date  
EG 427 Logo
EG 427
Board MemberMar 2021Apr 2026

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Health Care Early Stage Companies With More Than $1M in Revenue Logo
Health Care Early Stage Companies With More Than $1M in Revenue
29,354
European Union (EU) Early Stage Companies With Fewer Than 1000 Employees Logo
European Union (EU) Early Stage Companies With Fewer Than 1000 Employees
21,215
Life Science Early Stage Companies With More Than $1M in Revenue Logo
Life Science Early Stage Companies With More Than $1M in Revenue
45,930
Health Care Early Stage Companies With Less Than $500M in Revenue Logo
Health Care Early Stage Companies With Less Than $500M in Revenue
28,932
European Union (EU) Early Stage Companies With Fewer Than 50 Employees Logo
European Union (EU) Early Stage Companies With Fewer Than 50 Employees
28,166
Paris Early Stage Companies With More Than 10 Employees Logo
Paris Early Stage Companies With More Than 10 Employees
40,662
Biotechnology Early Stage Companies With Fewer Than 100 Employees Logo
Biotechnology Early Stage Companies With Fewer Than 100 Employees
26,505
Europe, Middle East, and Africa (EMEA) Life Science Companies Logo
Europe, Middle East, and Africa (EMEA) Life Science Companies
10,253
Ile-de-France Companies With Less Than $500M in Revenue (Top 10K) Logo
Ile-de-France Companies With Less Than $500M in Revenue (Top 10K)
7,308
Europe, Middle East, and Africa (EMEA) Health Care Companies with Early Stage Venture Funding Logo
Europe, Middle East, and Africa (EMEA) Health Care Companies with Early Stage Venture Funding
51,200

Education

Edit Education Section
Stephane Boissel studied at IAE Lyon School of Management, Université Paris-Dauphine, and  University of Chicago Booth School of Business.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Mar 1, 2021
EG 427 raised
obfuscation
from David Lamond and Stephane Boissel
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|